Bill Hoffman is a Venture Partner at Vensana Capital. Bill currently serves as a member of the board of directors of Inari Medical, where he held the CEO role from 2015 until 2022, leading the company through its initial public offering and helping to establish it as the global leader in the treatment of venous thromboembolism. He previously served as CEO at Visualase, a private company focused on MRI-guided laser ablation for the treatment of epilepsy and brain cancer, from 2008 until its acquisition by Medtronic in 2014. Prior to this, Bill served as VP Sales at FoxHollow Technologies, which pioneered atherectomy to treat peripheral artery disease and was acquired by ev3 in 2007. Bill received his BA in Economics from Dickinson College.